{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:15:04Z","timestamp":1792818904461,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070434\/H0214"],"award-info":[{"award-number":["82070434\/H0214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijcard.2024.131779","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T11:33:15Z","timestamp":1704972795000},"page":"131779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Relationship between hyperuricemia and the risk of cardiovascular events and chronic kidney disease in both the general population and hypertensive patients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"399","author":[{"given":"Li","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng\u2019ao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.131779_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179221","article-title":"Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease","volume":"22","author":"Yanai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcard.2024.131779_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/BOR.0000000000000679","article-title":"Asymptomatic hyperuricemia: is it really asymptomatic?","volume":"32","author":"Yip","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2015.08.109","article-title":"Regulation of uric acid metabolism and excretion","volume":"213","author":"Maiuolo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/jdi.12243","article-title":"Role of elevated serum uric acid levels at the onset of overt nephropathy in the risk for renal function decline in patients with type 2 diabetes","volume":"6","author":"Tanaka","year":"2015","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.ijcard.2024.131779_bb0025","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.ijcard.2024.131779_bb0030","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/HYPERTENSIONAHA.122.17956","article-title":"Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk","volume":"79","author":"Borghi","year":"2022","journal-title":"Hypertension."},{"key":"10.1016\/j.ijcard.2024.131779_bb0035","article-title":"Serum uric acid might be positively associated with hypertension in Chinese adults: an analysis of the China health and nutrition survey","volume":"8","author":"Han","year":"2021","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.ijcard.2024.131779_bb0040","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00392-021-01849-4","article-title":"Early onset of hyperuricemia is associated with increased cardiovascular disease and mortality risk","volume":"110","author":"Li","year":"2021","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0045","article-title":"Hyperuricemia and its association with ischemic stroke","volume":"13","author":"Padda","year":"2021","journal-title":"Cureus."},{"key":"10.1016\/j.ijcard.2024.131779_bb0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11906-020-01116-3","article-title":"Management of hyperuricemia in patients with chronic kidney disease: a focus on renal protection","volume":"22","author":"Kielstein","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ijcard.2024.131779_bb0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41440-021-00840-w","article-title":"Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease","volume":"45","author":"Nishizawa","year":"2022","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijcard.2024.131779_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13845","article-title":"The association of serum uric acid with metabolic syndrome and its components-from a single-clinical Centre in China","volume":"75","author":"Xu","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ijcard.2024.131779_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","article-title":"Uric acid in metabolic syndrome: does uric acid have a definitive role?","volume":"103","author":"Copur","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijcard.2024.131779_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/17843286.2020.1783907","article-title":"Non-alcoholic fatty liver disease: correlation with hyperuricemia in a European Mediterranean population","volume":"77","author":"Catanzaro","year":"2022","journal-title":"Acta Clin. Belg."},{"key":"10.1016\/j.ijcard.2024.131779_bb0075","article-title":"Prevalence of hyperuricemia among Chinese adults: findings from two nationally representative cross-sectional surveys in 2015-16 and 2018-19","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.nefroe.2021.10.008","article-title":"Hypertension mediated kidney and cardiovascular damage and risk stratification: redefining concepts","volume":"42","author":"M\u00e1rquez","year":"2022","journal-title":"Nefrologia (Engl. Ed.)."},{"key":"10.1016\/j.ijcard.2024.131779_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41440-022-00885-5","article-title":"Application of omics in hypertension and resistant hypertension","volume":"45","author":"Guo","year":"2022","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ijcard.2024.131779_bb0090","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s12889-021-10858-x","article-title":"Combined effect of hypertension and hyperuricemia on ischemic stroke in a rural Chinese population","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ijcard.2024.131779_bb0095","first-page":"21","article-title":"Hyperuricemia and hypertension, coronary artery disease, kidney disease: from concept to practice","author":"Gaubert","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcard.2024.131779_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11906-016-0684-z","article-title":"Hyperuricemia, hypertension, and chronic kidney disease: an emerging association","volume":"18","author":"Mallat","year":"2016","journal-title":"Curr. Hypertens. Rep."},{"issue":"264\u20139","key":"10.1016\/j.ijcard.2024.131779_bb0105","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2024.131779_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0115","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/10641963.2021.1907397","article-title":"Association of hyperuricemia and hypertension phenotypes in hypertensive patients without uric acid lowering treatment","volume":"43","author":"Liu","year":"2021","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.ijcard.2024.131779_bb0120","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004177","article-title":"Hyperuricemia and uncontrolled hypertension in treated hypertensive patients: K-MetS Study","volume":"95","author":"Cho","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijcard.2024.131779_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acr.20344","article-title":"Hyperuricemia and incident hypertension: a systematic review and meta-analysis","volume":"63","author":"Grayson","year":"2011","journal-title":"Arthritis Care Res."},{"issue":"12","key":"10.1016\/j.ijcard.2024.131779_bb0130","doi-asserted-by":"crossref","first-page":"e114259","DOI":"10.1371\/journal.pone.0114259","article-title":"Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2024.131779_bb0135","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1681\/ASN.2014070660","article-title":"Uric acid and cardiovascular events: a Mendelian Randomization Study","volume":"26","author":"Kleber","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/01616412.2018.1553347","article-title":"Hyperuricemia and prognosis of acute ischemic stroke in diabetic patients","volume":"41","author":"Wang","year":"2019","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ijcard.2024.131779_bb0145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ndt\/gft378","article-title":"Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis","volume":"29","author":"Bose","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ijcard.2024.131779_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187550","article-title":"Effects of uric acid-lowering therapy in patients with chronic kidney disease: a meta-analysis","volume":"12","author":"Su","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2024.131779_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/1755-5922.12215","article-title":"Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"34","author":"Xin","year":"2016","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ijcard.2024.131779_bb0160","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2013.11.051","article-title":"Hyperuricemia and risk of stroke: a systematic review and meta-analysis of prospective studies","volume":"232","author":"Li","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.ijcard.2024.131779_bb0165","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"Kim","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.ijcard.2024.131779_bb0170","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ijcard.2018.06.017","article-title":"Cross-sectional and longitudinal associations between serum uric acid and endothelial function in subjects with treated hypertension","volume":"272","author":"Tanaka","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0175","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijcard.2018.07.121","article-title":"Uric acid and early prevention of vascular diseases: women under the looking glass","volume":"272","author":"Borghi","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/523897","article-title":"Hyperuricemia and incident cardiovascular disease and noncardiac vascular events in patients with rheumatoid arthritis","volume":"2014","author":"Kuo","year":"2014","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0185","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/1471-2474-14-347","article-title":"Risk factors for incident hyperuricemia during mid-adulthood in African American and white men and women enrolled in the ARIC cohort study","volume":"14","author":"McAdams-DeMarco","year":"2013","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.ijcard.2024.131779_bb0190","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","article-title":"Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years","volume":"75","author":"Virdis","year":"2020","journal-title":"Hypertension."},{"key":"10.1016\/j.ijcard.2024.131779_bb0195","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1159\/000491609","article-title":"U-shaped relationship between functional outcome and serum uric acid in ischemic stroke","volume":"47","author":"Yang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ijcard.2024.131779_bb0200","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1159\/000509258","article-title":"Relationship between serum uric acid and mortality risk in hemodialysis patients: a multicenter prospective cohort study","volume":"51","author":"Yang","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5114\/aoms.2019.84397","article-title":"Association of anti-hyperuricemia treatment and prevalent cardiovascular disease in hypertensive patients","volume":"16","author":"Zeng","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ijcard.2024.131779_bb0210","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1053\/j.ajkd.2017.12.009","article-title":"Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation","volume":"71","author":"Johnson","year":"2018","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ijcard.2024.131779_bb0215","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41371-021-00613-5","article-title":"Identification of a plausible serum uric acid cut-off value as prognostic marker of stroke: the Uric Acid Right for Heart Health (URRAH) study","volume":"36","author":"Tikhonoff","year":"2022","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.ijcard.2024.131779_bb0220","first-page":"13","article-title":"Serum uric acid predicts all-cause and cardiovascular mortality independently of hypertriglyceridemia in Cardiometabolic patients without established CV disease: a sub-analysis of the URic acid Right for heArt Health (URRAH) study","author":"Mengozzi","year":"2023","journal-title":"Metabolites."},{"key":"10.1016\/j.ijcard.2024.131779_bb0225","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/HJH.0000000000001927","article-title":"Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study","volume":"37","author":"Cicero","year":"2019","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2024.131779_bb0230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijcard.2018.03.077","article-title":"LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: data from the Brisighella Heart Study cohort","volume":"261","author":"Cicero","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.131779_bb0235","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3810\/pgm.2013.01.2626","article-title":"Preservation of renal function during gout treatment with febuxostat: a quantitative study","volume":"125","author":"Whelton","year":"2013","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.ijcard.2024.131779_bb0240","first-page":"6","article-title":"Effect of febuxostat on ambulatory blood pressure in subjects with hyperuricemia and hypertension: a phase 2 randomized placebo-controlled study","author":"Gunawardhana","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.131779_bb0245","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","article-title":"Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial","volume":"396","author":"Mackenzie","year":"2020","journal-title":"Lancet."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324001098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324001098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:04:24Z","timestamp":1759093464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324001098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":49,"alternative-id":["S0167527324001098"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131779","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between hyperuricemia and the risk of cardiovascular events and chronic kidney disease in both the general population and hypertensive patients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.131779","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131779"}}